Test Price
2,800 AED✅ Home Collection Available
LMNA Gene Hutchinson-Gilford Progeria Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل الجين LMNA لمتلازمة هاتشينسون غيلفورد بروجيريا في الإمارات | ٢٨٠٠ درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-certified genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ملخص تنفيذي: يقدم هذا الاختبار تحليلًا جينيًا متقدمًا لجين LMNA باستخدام تقنية التسلسل من الجيل التالي للكشف الدقيق عن متلازمة بروجيريا هاتشينسون-غيلفورد. نضمن دقة تشخيصية تصل إلى 99.9% من خلال معالجة معتمدة بمعيار ISO 9001:2015. السحب المنزلي الآمن بدرجة حرارة مراقبة مع استشارة سريرية بعد الاختبار. التحقق من التأمين عبر واتساب على 054548731. إرشادات 2026 من هيئة الصحة بدبي.
Clinical Overview
The LMNA NGS test comprehensively sequences the full LMNA gene to detect classic c.1824C>T and rare variants causing Hutchinson-Gilford progeria syndrome (HGPS), enabling precise diagnosis, family screening, and proactive pediatric management. اختبار متقدم لتحديد الطفرات المسببة لمرض بروجيريا الطفولة المبكرة.
| Feature | Our Test (NGS Full LMNA) | Closest Alternative (Sanger Hotspot) |
|---|---|---|
| Coverage | All exons, flanking splice sites + CNV detection | Only exon 11 (c.1824C>T hotspot) |
| Method | Next-Generation Sequencing (NGS) with MLPA backup | Sanger sequencing |
| Turnaround Time | 3 – 4 Weeks | 2 – 3 Weeks |
| Diagnostic Sensitivity | >99% (full gene analysis) | ~90% (misses non-classic mutations) |
| Certification | ISO 9001:2015 / DHA Licensed Facility (9834453) | Often not accredited for NGS |
Physician Insight & Safety Protocol
“As a clinical geneticist, I recognise the anxiety a family feels when progeria is suspected. This test provides molecular clarity, but results must always be interpreted alongside a thorough clinical evaluation. No single genetic variant replaces the nuanced judgment of a specialist; we are here to guide you through every step of diagnosis, management, and genetic counselling.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Critical Medication Warning:
Do not discontinue or modify any prescribed medication(s) without first consulting your treating physician or the consultant geneticist managing your child’s care. This genetic test does not override ongoing therapies.
🛡️ Exclusion Criteria & Emergency Red Flags
- Patient must not be in an acute critical care episode (e.g., severe respiratory distress, uncontrolled seizures) that would compromise sample collection.
- Minor patients require written informed consent from both parents or legal guardian, as per UAE CDS Law 2026 for genetic testing in children.
- Active systemic infection or haemodynamic instability — postpone sample until stabilisation.
- ER Red Flag: If the child presents with acute chest pain, sudden visual loss, or stroke-like symptoms, seek emergency care immediately — not a genetics lab.
- This test is not for asymptomatic adult screening without prior genetic counselling and documented family history.
Patient FAQ & Clinical Guidance
1. What exactly does the LMNA NGS test for progeria detect and why is it important?
This test detects pathogenic DNA variants in the entire LMNA gene that cause Hutchinson-Gilford progeria syndrome, enabling early diagnosis and tailored multidisciplinary care planning.
يكتشف هذا الاختبار الطفرات الممرضة في جين LMNA المسببة لمتلازمة بروجيريا هاتشينسون-غيلفورد، مما يتيح التشخيص المبكر ووضع خطة رعاية متعددة التخصصات.
2. How long will it take to receive the test results and what do they mean?
Results are delivered within 3 to 4 weeks, and a positive finding indicates a concrete molecular basis for progeria, guiding cardiology, orthopaedic, and nutritional interventions.
تظهر النتائج خلال 3-4 أسابيع، وتشير النتيجة الإيجابية إلى أساس جزيئي مؤكد للبروجيريا مما يوجه التدخلات الطبية المختلفة.
3. Is a blood sample from a one‑day‑old infant sufficient for this advanced DNA?
Absolutely, the laboratory can process DNA extracted from a tiny drop of blood on an FTA card, umbilical cord blood, or whole blood, making it safe for newborns.
نعم، يمكن للمختبر معالجة الحمض النووي المستخلص من قطرة دم واحدة على بطاقة FTA أو دم الحبل السري أو الدم الكامل، مما يجعله آمنًا للمواليد الجدد.
UAE Legal & Regulatory Compliance:
This service fully adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on medical liability, the CDS Law 2026 regarding genetic testing in minors, and the UAE PDPL for personal data privacy. All genetic data is handled with the highest security standards under our ISO 9001:2015 certification and DHA facility licence 9834453. Home collection is performed by licensed phlebotomists following cold-chain protocols.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians